The Role of the p75 Neurotrophin Receptor in Dopaminergic Neurodegeneration Induced by Oxidative Stress.

p75 神经营养素受体在氧化应激诱导的多巴胺能神经变性中的作用。

基本信息

  • 批准号:
    10437963
  • 负责人:
  • 金额:
    $ 43.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Neurodegenerative diseases, which are characterized by progressive neural dysfunction and neuronal death, are a common cause of morbidity and mortality in the elderly. Because current treatment strategies for most neurodegenerative disorders are palliative rather than curative, there is an urgent need for novel treatment strategies that reduce or prevent progressive neurodegeneration. The p75 neurotrophin receptor (p75NTR) is a transmembrane protein that has been demonstrated to regulate the death of neurons affected by a variety of pathological conditions. Despite this known role, how the receptor is activated in damaged neurons and the mechanisms through which it regulates cell death are poorly understood. Using cultured dopaminergic cells, we recently discovered a novel, ligand-independent mechanism through which p75NTR is activated in response to oxidative stress. However, the signaling events associated with this new receptor activation mechanism and the physiological consequences of such events remain incompletely understood. Investigations in this regard may be particularly important to understanding the progression of Parkinson’s disease, a disorder associated with oxidative stress and progressive degeneration of dopaminergic neurons in the substantia nigra of the ventral midbrain. With these considerations, we propose to evaluate the effects of p75NTR on dopaminergic neurodegeneration in cell culture and animal models of Parkinson’s disease. Aim I of this application is to characterize the mechanisms through which oxidative stress induces p75NTR signaling. Biochemical assays will be performed using lysates of cultured cells to identify the roles of various p75NTR interactors in oxidative stress-induced p75NTR signaling. Aim II of the proposed work is to use blockade of p75NTR signaling by siRNA-mediated knockdown, genetic deletion, or pharmacological inhibition to evaluate the effects of the receptor on dopaminergic neurodegeneration in cell culture or mouse models of Parkinson’s disease. Since axonal degeneration in dopaminergic neurons is a key, early-stage event that precedes neuronal death in individuals with Parkinson’s disease, Aim III of the proposed research project is to evaluate the effects of p75NTR signaling on axonal degeneration induced by oxidative stress. All studies in this proposal will involve undergraduate students at Eastern Kentucky University (EKU). These students will also participate in weekly lab meetings and receive personal mentorship in science literacy, experimental design, research methodology, data analysis, and communication of findings. By supporting this meritorious research, an AREA grant would provide impactful research experiences for students and strengthen the scientific environment at EKU, an institution with accelerating emphasis on biomedical research.
神经退行性疾病,以进行性神经功能障碍和神经元为特征 死亡,是老年人发病和死亡的常见原因。因为目前的治疗策略 大多数神经退行性疾病是缓解而不是治愈的,迫切需要新的 减少或防止进行性神经变性的治疗策略。P75神经营养素受体 (P75ntr)是一种跨膜蛋白,已被证明调节受 各种病理情况。尽管有这种已知的作用,但在受损神经元中受体是如何被激活的 它调节细胞死亡的机制也鲜为人知。利用培养的多巴胺能 细胞,我们最近发现了一种新的、不依赖于配体的机制,通过这种机制,p75NTR在 对氧化应激的反应。然而,与这种新的受体激活相关的信号事件 这类事件的机制和生理后果仍不完全清楚。 这方面的研究对于了解帕金森氏症的进展可能特别重要 疾病,一种与氧化应激和多巴胺能神经元进行性变性有关的疾病 中脑腹侧的黑质。考虑到这些因素,我们建议评估以下措施的效果 P75NTR在细胞培养和帕金森病动物模型中对多巴胺能神经变性的影响。目标I: 这一应用是为了研究氧化应激诱导p75NTR信号转导的机制。 生化分析将使用培养细胞的裂解物来确定各种p75NTR的作用。 氧化应激诱导的p75NTR信号转导中的相互作用。拟议工作的目标二是利用封锁 通过siRNA介导的基因敲除、基因缺失或药物抑制来评估p75NTR信号转导 受体在细胞培养和帕金森病小鼠模型多巴胺能神经变性中的作用 疾病。因为多巴胺能神经元轴突变性是先于 帕金森氏病患者的神经元死亡,拟议研究项目的目标III是评估 P75NTR信号在氧化应激诱导的轴突变性中的作用。本提案中的所有研究 将涉及东肯塔基大学(EKU)的本科生。这些学生也将参加 在每周的实验室会议上,接受科学素养、实验设计、研究等方面的个人指导 方法、数据分析和调查结果的交流。通过支持这项有价值的研究,一个领域 格兰特将为学生提供有影响力的研究经验,并加强 EKU,一个加速重视生物医学研究的机构。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRADLEY R KRAEMER其他文献

BRADLEY R KRAEMER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 43.8万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 43.8万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了